Cooperativity basis for small-molecule stabilization of protein-protein interactions

被引:32
|
作者
de Vink, Pim J. [1 ,2 ]
Andrei, Sebastian A. [1 ,2 ]
Higuchi, Yusuke [3 ]
Ottmann, Christian [1 ,2 ,4 ]
Milroy, Lech-Gustav [1 ,2 ]
Brunsveld, Luc [1 ,2 ]
机构
[1] Eindhoven Univ Technol, Lab Chem Biol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands
[2] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands
[3] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Japan
[4] Univ Duisburg Essen, Dept Organ Chem, Duisburg, Germany
关键词
ALLOSTERIC LIGANDS; STRUCTURAL BASIS; BINDING; DEGRADATION; DOMAIN;
D O I
10.1039/c8sc05242e
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A cooperativity framework to describe and interpret small-molecule stabilization of protein-protein interactions (PPI) is presented. The stabilization of PPIs is a versatile and emerging therapeutic strategy to target specific combinations of protein partners within the protein interactome. Currently, the potency of PPI stabilizers is typically expressed by their apparent affinity or EC50. Here, we propose that the effect of a PPI stabilizer be best described involving the cooperativity factor, alpha, between the stabilizer and binding partners in addition to the intrinsic affinity, K-D(II), of the stabilizer for one of the apo-proteins. By way of illustration, we combine fluorescence polarization measurements with thermodynamic modeling to determine the a and K-D(II) for the PPI stabilization of 14-3-3 and TASK3 by fusicoccin-A (FC-A) and validate our approach by studying other PPI-partners of 14-3-3 proteins. Finally, we characterize a library of different stabilizer compounds, and perform structure-activity relationship studies in which molecular changes could be attributed to either changes in cooperativity or intrinsic affinity. Such insights should aid in the development of more effective protein-protein stabilizer drugs.
引用
收藏
页码:2869 / 2874
页数:6
相关论文
共 50 条
  • [41] Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface
    Bier, David
    Bartel, Maria
    Sies, Katharina
    Halbach, Sebastian
    Higuchi, Yusuke
    Haranosono, Yu
    Brummer, Tilman
    Kato, Nobuo
    Ottmann, Christian
    CHEMMEDCHEM, 2016, 11 (08) : 911 - 918
  • [42] Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
    Michelle R. Arkin
    James A. Wells
    Nature Reviews Drug Discovery, 2004, 3 : 301 - 317
  • [43] A Screen to Identify Small Molecule Inhibitors of Protein-Protein Interactions in Mycobacteria
    Mai, Deborah
    Jones, Jennifer
    Rodgers, John W.
    Hartman, John L.
    Kutsch, Olaf
    Steyn, Adrie J. C.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2011, 9 (03) : 299 - 310
  • [44] Molecular basis for protein-protein interactions
    Seychell, Brandon Charles
    Beck, Tobias
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2021, 17 : 1 - 10
  • [45] Small Molecule Modulators of Protein-Protein Interactions: Selected Case Studies
    Aeluri, Madhu
    Chamakuri, Srinivas
    Dasari, Bhanudas
    Guduru, Shiva Krishna Reddy
    Jimmidi, Ravikumar
    Jogula, Srinivas
    Arya, Prabhat
    CHEMICAL REVIEWS, 2014, 114 (09) : 4640 - 4694
  • [46] Small-molecule modulators of protein-RNA interactions
    Byun, Wan Gi
    Lim, Donghyun
    Park, Seung Bum
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2022, 68
  • [47] Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein Protein Interaction
    Blevitt, Jonathan M.
    Hack, Michael D.
    Herman, Krystal L.
    Jackson, Paul F.
    Krawczuk, Paul J.
    Lebsack, Alec D.
    Liu, Annie X.
    Mirzadegan, Taraneh
    Nelen, Marina I.
    Patrick, Aaron N.
    Steinbacher, Stefan
    Milla, Marcos E.
    Lumb, Kevin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (08) : 3511 - 3517
  • [48] Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein-Protein Interactions by Bioisostere Replacement
    Yu, Binxun
    Huang, Zheng
    Zhang, Min
    Dillard, Darren R.
    Ji, Haitao
    ACS CHEMICAL BIOLOGY, 2013, 8 (03) : 524 - 529
  • [49] IP-FCM Measures Physiologic Protein-Protein Interactions Modulated by Signal Transduction and Small-Molecule Drug Inhibition
    Smith, Stephen E. P.
    Bida, Anya T.
    Davis, Tessa R.
    Sicotte, Hugues
    Patterson, Steven E.
    Gil, Diana
    Schrum, Adam G.
    PLOS ONE, 2012, 7 (09):
  • [50] Toward Small-molecule Inhibition of Protein-protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions
    Bojadzic, Damir
    Buchwald, Peter
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (08) : 674 - 699